IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Transition Therapeutics Inc

CUSIP: 893716209 | 54 institutional holders

Quarters

Q3 2016Q2 2016Q1 2016Q4 2015Q3 2015
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2016

Hollencrest Capital Management188,596
0.0% of portfolio›$283
Birchview Capital, LP23,866
0.0% of portfolio›$36
StyleTurnoverLocationFiled
Hollencrest Capital Management
188,596$2830.0%ETFLowNewport Beach, CA2016-10-12
Birchview Capital, LP
23,866$360.0%CoreHighBurlington, VT2016-11-14